Cardiff Oncology

IPO

Cardiff Oncology is a biotech company in San Diego, United States, founded in 1999. It has raised $55.0M across 2 rounds, most recently a $40.0M Growth Equity in December 2024.

Employees
11–50
Founded
1999
Business Model
B2B
Total Funding
$55.0M
Last Round
$40.0M Growth EquityDec 2024
Rounds
2
Type
Public

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 2 funding rounds and 4 investors for this company. The full record is or through the API.

About

Cardiff Oncology develops novel therapies across a range of cancers by targeting PLK1 inhibition. Its lead asset, onvansertib, is being evaluated alongside standard-of-care therapeutics, combining an investigational PLK1 inhibitor with existing treatment approaches as part of its cancer therapy development work.

Summary

It lists 11–50 employees. It has raised $55.0M in total across 2 rounds, most recently a $40.0M Growth Equity round in Dec 2024. Investors include Pfizer Ventures, Frazier Healthcare and Acorn Bioventures.

Tech & App Stack

5 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding & Exit History

Data from Indexed.vcUpdated
Post-IPO EquityRegistered Direct OfferingJul 2026
$10.0M

Sign up to see all 4 events

Funding: Corporate Round through Growth Equity. Amounts, valuations, and investors where available.

Investors

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Cardiff Oncology on Indexed.vc
<a href="https://indexed.vc/companies/cardiff-oncology"><img src="https://indexed.vc/api/badge/company/cardiff-oncology" alt="Cardiff Oncology on Indexed.vc" width="260" height="76" /></a>